Psychopharmacology Maastricht
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn More
Maastricht Psychedelic Symposium
On May 24, the Maastricht Psychedelic Research Team organized a mini-symposium on psychedelics. We welcomed two international speakers: Prof. dos Santos and Prof. Bouso from Brazil and Spain to discuss their ayahuasca and ibogaine research. We also had several internal speakers: presenting on mystical vs. autobiographical psychedelic experiences (Dr Kangaslampi), microdosing (Ms. Haijen), and 5-MeO-DMT (Mr. Reckweg).
Click below to watch the entire symposium
Read about our new paper on the neurological origins of a visual psychedelic hallucination
Congratulations to Zeus Tipado on his newly published paper that introduces a new theory as to why a person experiences a visual trip on psychedelics.
Read The PaperParticipate in our studies!
We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.
View All Studies
Our Scientists
Dr. Natasha Mason
Plasticity, Psychedelics, Neuroadaptations
My research is driven by my desire to find effective treatments for psychiatric disorders, particularly anxiety, depression, and post-traumatic stress disorder.
Sarah Roche, MSc
Psilocybin, Sustainability, Environment
My PhD research focuses on psychedelic drugs as a tool to investigate the cognitive mechanisms underlying changes in sustainable behavior.
Iva Totomanova, MSc
My primary research interest lies in exploring the potential of psychedelics to be used as novel treatment options for a range of psychiatric disorders.
Lorena Guerra, MSc
I am Lorena, a PhD candidate from Brazil with experience working on preclinical and clinical research.
Dr. C. Rob Markus
I became an expert on the relation between stress, brain (gene) vulnerability and the development of cognitive-affective complaints/disorders as well as in testing (claims about) dietary treatment/assessment methods.
Johannes Reckweg, MSc
5-MeO-DMT, Neuropsychopharmacology, Therapy
I am Johannes, a PhD candidate from Germany. After receiving my Bachelor’s degree from the Rijksuniversiteit Groningen, I came to Maastricht for my Master in Neuropsychology.
Zain Gangaram, MSc
My research is multifaceted and is based on an RDoC model for Reactive Aggression (RA).
Pablo Mallaroni, MSc
Psychedelics, fMRI/MRS, Idiosyncracy
I am PhD candidate with the Psychopharmacology Unit of Maastricht University with a background in translational neuroscience.
Mauro Cavarra, MSc
Psychosomatics, Chronic Pain, Psychedelic-Assisted Psychotherapy
I am a psychotherapist, hypnotherapist and clinical trainer interested in understanding the connection between mind and body. At the Department I work in research projects that explore the potential of psychedelic therapies in the treatment...
Psychedelic Research
Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions
hallucinations, visual, Psychedelics, vision, retinofugal, tripping
→
Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking
Ayahuasca, creativity, divergent thinking, convergent thinking
→
Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study
→
Cannabis Research
Medicinal Δ9-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests
→
Intoxication by a synthetic cannabinoid (JWH-018) causes cognitive and psychomotor impairment in recreational cannabis users
Psychomotor, Cannabis, Cognition
→
Get in Touch
We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.